ACT: Applied Research Abstract Presentations

Friday, March 11, 2022

1:30 PM – 2:30 PM CST

Location:Coronado

Moderator(s)

Joseph Skitzki, MD

Associate Professor of Surgical Oncology, Surgery, Immunology
Roswell Park Comprehensive Cancer Center, United States
Maheswari Senthil, MD

Chief of Surgical Oncology
University of California, Irvine
Irvine, California, United States

Participants should be aware of the following financial/non-financial relationships:

Joseph Skitzki, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Maheswari Senthil, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

1:31 PM – 1:39 PM CST

A44: Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Obstructive Jaundice
Abstract Presenter: Joy Sarkar, MD – Roswell Park Comprehensive Cancer Center
1:39 PM – 1:41 PM CST

A44: Q&A
Abstract Presenter: Joy Sarkar, MD – Roswell Park Comprehensive Cancer Center
1:41 PM – 1:49 PM CST

A42: A Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with anti-pd1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma
Abstract Presenter: Nicholas A. Ullman, MD – University of Rochester Medical Center
1:49 PM – 1:51 PM CST

A42: Q&A
Abstract Presenter: Nicholas A. Ullman, MD – University of Rochester Medical Center
1:51 PM – 1:59 PM CST

A43: Co-clinical Trial of Novel Bispecific anti-her2 Antibody Zanidatamab in Patient-derived Xenografts Developed on a Phase I Trial
Abstract Presenter: Timothy P. DiPeri, MD – The University of Texas MD Anderson Cancer Center
1:59 PM – 2:01 PM CST

A43: Q&A
Abstract Presenter: Timothy P. DiPeri, MD – The University of Texas MD Anderson Cancer Center
2:01 PM – 2:09 PM CST

A28: Exosome Liquid Biopsy in Colon Cancer Utilizing RNA Biomarkers: An Initial Analysis
Abstract Presenter: Jingjing Yu, MD – University of California, Irvine Medical Center
2:09 PM – 2:11 PM CST

A28: Q&A
Abstract Presenter: Jingjing Yu, MD – University of California, Irvine Medical Center
2:11 PM – 2:19 PM CST

A45: Early Observations from Clinical Trial of Intra-arterial Curaxin CBL0137
Abstract Presenter: Joseph Skitzki, MD – Roswell Park Comprehensive Cancer Center
2:19 PM – 2:21 PM CST

A45: Q&A
Abstract Presenter: Joseph Skitzki, MD – Roswell Park Comprehensive Cancer Center
2:21 PM – 2:29 PM CST

A47: Intratumoral Density of Regulatory T Cells Is a Predictor of Host Immune Response and Chemotherapy Response Rate in Metastases from Colorectal Cancer
Abstract Presenter: Joy Sarkar, MD – Roswell Park Comprehensive Cancer Center
2:29 PM – 2:30 PM CST

A47: Q&A
Abstract Presenter: Joy Sarkar, MD – Roswell Park Comprehensive Cancer Center